Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 2
2007 4
2008 2
2009 1
2010 2
2011 1
2013 2
2014 7
2015 3
2016 5
2017 3
2018 3
2019 6
2020 7
2021 12
2022 9
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Targeting mitochondrial impairment for the treatment of cardiovascular diseases: From hypertension to ischemia-reperfusion injury, searching for new pharmacological targets.
Todisco S, Musio B, Pesce V, Cavalluzzi MM, Petrosillo G, La Piana G, Sgobba MN, Schlosserová N, Cafferati Beltrame L, Di Lorenzo R, Tragni V, Marzulli D, Guerra L, De Grassi A, Gallo V, Volpicella M, Palese LL, Lentini G, Pierri CL. Todisco S, et al. Among authors: de grassi a. Biochem Pharmacol. 2023 Feb;208:115405. doi: 10.1016/j.bcp.2022.115405. Epub 2023 Jan 2. Biochem Pharmacol. 2023. PMID: 36603686 Review.
Translational Theragnosis of Ovarian Cancer: where do we stand?
Perrone MG, Luisi O, De Grassi A, Ferorelli S, Cormio G, Scilimati A. Perrone MG, et al. Among authors: de grassi a. Curr Med Chem. 2020;27(34):5675-5715. doi: 10.2174/0929867326666190816232330. Curr Med Chem. 2020. PMID: 31419925 Review.
Personalized Medicine in Mitochondrial Health and Disease: Molecular Basis of Therapeutic Approaches Based on Nutritional Supplements and Their Analogs.
Tragni V, Primiano G, Tummolo A, Cafferati Beltrame L, La Piana G, Sgobba MN, Cavalluzzi MM, Paterno G, Gorgoglione R, Volpicella M, Guerra L, Marzulli D, Servidei S, De Grassi A, Petrosillo G, Lentini G, Pierri CL. Tragni V, et al. Among authors: de grassi a. Molecules. 2022 May 29;27(11):3494. doi: 10.3390/molecules27113494. Molecules. 2022. PMID: 35684429 Free PMC article. Review.
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Giebel S, Labopin M, Salmenniemi U, Socié G, Bondarenko S, Blaise D, Kröger N, Vydra J, Grassi A, Bonifazi F, Czerw T, Anagnostopoulos A, Lioure B, Ruggeri A, Savani B, Spyridonidis A, Sanz J, Peric Z, Nagler A, Ciceri F, Mohty M. Giebel S, et al. Among authors: grassi a. Cancer. 2023 Dec 1;129(23):3735-3745. doi: 10.1002/cncr.35004. Epub 2023 Sep 1. Cancer. 2023. PMID: 37658621
RUNX1 gene alterations characterized by allelic preference in adult acute myeloid leukemia.
Cumbo C, Tota G, De Grassi A, Anelli L, Zagaria A, Coccaro N, Tarantini F, Minervini CF, Parciante E, Impera L, Conserva MR, Redavid I, Mestice A, Attolico I, Pierri CL, Musto P, Albano F. Cumbo C, et al. Among authors: de grassi a. Leuk Lymphoma. 2023 Mar;64(3):717-721. doi: 10.1080/10428194.2021.1929960. Epub 2021 May 24. Leuk Lymphoma. 2023. PMID: 34027815 No abstract available.
68 results